PT1169316E - Novos derivados do acido lipoico sua preparacao e composicoes farmaceuticas que os contem - Google Patents

Novos derivados do acido lipoico sua preparacao e composicoes farmaceuticas que os contem

Info

Publication number: PT1169316E
Authority: PT; Portugal
Prior art keywords: contain; preparation; pharmaceutical compositions; lipoic acid; new derivatives
Prior art date: 1999-04-02

Application number

PT00918930T

Other languages

English (en)

Inventor

Pierre-Etienne Cha Lassauniere

Jeremiah Harnett

Michael Auguet

Original Assignee

Scras

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-02

Filing date

2000-03-31

Publication date

2003-07-31

1999-04-02 Priority claimed from FR9904132A external-priority patent/FR2791677B1/fr

2000-02-24 Priority claimed from FR0002315A external-priority patent/FR2805537A1/fr

2000-03-31 Application filed by Scras filed Critical Scras

2003-07-31 Publication of PT1169316E publication Critical patent/PT1169316E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Reproductive Health (AREA)
Biochemistry (AREA)
Gynecology & Obstetrics (AREA)
Virology (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Anesthesiology (AREA)

PT00918930T 1999-04-02 2000-03-31 Novos derivados do acido lipoico sua preparacao e composicoes farmaceuticas que os contem PT1169316E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9904132A FR2791677B1 (fr)	1999-04-02	1999-04-02	Nouveaux derives de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR0002315A FR2805537A1 (fr)	2000-02-24	2000-02-24	Nouveaux derives de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number	Publication Date
PT1169316E true PT1169316E (pt)	2003-07-31

Family

ID=26212205

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT00918930T PT1169316E (pt)	1999-04-02	2000-03-31	Novos derivados do acido lipoico sua preparacao e composicoes farmaceuticas que os contem

Country Status (20)

Country	Link
US (2)	US6605637B1 (pt)
EP (1)	EP1169316B9 (pt)
JP (1)	JP2003505341A (pt)
KR (1)	KR100758763B1 (pt)
CN (1)	CN1173969C (pt)
AR (1)	AR042572A1 (pt)
AT (1)	ATE233752T1 (pt)
AU (1)	AU763572B2 (pt)
CA (1)	CA2369071A1 (pt)
DE (1)	DE60001546T9 (pt)
DK (1)	DK1169316T3 (pt)
ES (1)	ES2193949T3 (pt)
HK (1)	HK1046134B (pt)
HU (1)	HUP0200863A3 (pt)
MY (1)	MY119231A (pt)
NZ (1)	NZ514888A (pt)
PL (1)	PL350994A1 (pt)
PT (1)	PT1169316E (pt)
TW (1)	TWI269794B (pt)
WO (1)	WO2000059899A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19941217A1 (de) *	1999-08-30	2001-03-15	Asta Medica Ag	Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben
DE60108089T2 (de) *	2000-03-16	2006-03-02	Societe De Conseils De Recherches Et D`Applications Scientifiques (S.C.R.A.S.)	Heterozyklische oder Benzol-Derivate von Liponsäure, deren Herstellung und Ederen Verwendung als Heilmittel
IT1319196B1 (it) *	2000-10-10	2003-09-26	Laboratorio Chimico Int Spa	Sintesi dell'acido r(+)alfa-lipoico.
WO2002044163A2 (de)	2000-11-30	2002-06-06	Basf Aktiengesellschaft	Verfahren zur herstellung von liponsäure und dihydroliponsaüre
DE10137381A1 (de) *	2001-07-31	2003-02-13	Viatris Gmbh	Neue Modifikationen des Trometamolsalzes der R-Thioctsäure sowie Verfahren zu ihrer Herstellung
AU2002334755B2 (en) *	2001-09-28	2007-12-06	Meagan Medical, Inc.	Method and apparatus for controlling percutaneous electrical signals
WO2004043485A1 (fr) *	2002-11-10	2004-05-27	Institute Of Cell Biophysics Russian Academy Of Sciences	Composition presentant des proprietes antioxydantes, procede de production d'un polypeptide et methode de traitement
US7202270B2 (en) *	2003-06-20	2007-04-10	Sami Labs Limited	Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
US8916546B2 (en)	2003-08-29	2014-12-23	Therapeutic Research Llc	Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US20070299093A1 (en) *	2005-01-27	2007-12-27	Alma Mater Studiorum-Universitá Di Bologna	Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
CN101146800A (zh)	2005-01-27	2008-03-19	生物工程大学精神物质实验室	用于治疗阿尔茨海默病的有机化合物，它们的用途和制备方法
DK1754478T3 (da)	2005-08-04	2009-05-04	Encrypta Gmbh	Flydende sammensætning omfattende arginin og alfa-liponsyre og anvendelse heraf til forbedring af den seksuelle funktion
FR2908769B1 (fr) *	2006-11-17	2008-12-26	Oreal	Nouveaux composes derives dithiolanes silicies et leur utilisation
JP2010520333A (ja) *	2007-03-01	2010-06-10	セダーズ−シナイメディカルセンター	〔１，２〕−ジチオラン部分を含有する抗酸化剤重合体およびその使用
EP2139321B1 (en)	2007-04-18	2013-11-06	Cornerstone Pharmaceuticals, Inc.	Lipoic acid derivatives
BRPI0812729A2 (pt)	2007-06-13	2019-02-12	Pravda Jay	materiais e métodos para tratamento e diagnósticos de distúrbios associados com estresse oxidativo
DE102007038849A1 (de)	2007-08-16	2009-02-19	Adscil Gmbh	Verwendung von R(+)-alpha-Liponsäure zur Behandlung der kryptogenen Neuropathie
WO2009086547A1 (en) *	2008-01-03	2009-07-09	Cedars-Sinai Medical Center	Antioxidant nanosphere comprising [1,2]-dithiolane moieties
JP2011516473A (ja) *	2008-04-04	2011-05-26	ショール，ロバート	医薬組成物
WO2009148698A1 (en)	2008-06-02	2009-12-10	Cedars-Sinai Medical Center	Nanometer-sized prodrugs of nsaids
FR2937035B1 (fr) *	2008-10-10	2010-12-31	Oreal	Composes dithiolanes ; compositions les contenant ; utilisations pour la photoprotection de la peau
EP2350274B1 (en)	2008-10-21	2019-01-23	The General Hospital Corporation	Cell transplantation
EP2370435B1 (en)	2008-11-24	2015-01-07	Cedars-Sinai Medical Center	Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
CN102395560A (zh) *	2009-02-17	2012-03-28	因瓦斯科医疗有限公司	包括一氧化氮的二氢硫辛酸衍生物及其治疗应用
US8632512B2 (en)	2010-04-09	2014-01-21	Kci Licensing, Inc.	Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
EP3530741B1 (en)	2010-08-06	2021-04-07	The General Hospital Corporation D/B/A Massachusetts General Hospital	System and apparatus for cell treatment
US8529873B2 (en)	2011-08-24	2013-09-10	Los Alamos National Security, Llc	SE-72/AS-72 generator system based on Se extraction/ As reextraction
CA2891090A1 (en)	2012-11-09	2014-05-15	Scidose, Llc	Enema composition for treatment of ulcerative colitis having long term stability
EP3188726B1 (en)	2014-06-19	2019-08-07	Rafael Pharmaceuticals, Inc.	Pharmaceutical compounds
CA2965963A1 (en)	2014-06-19	2015-12-23	Robert Shorr	Lipoic acid derivatives for pharmaceutical use
CN105949180B (zh) *	2016-05-10	2018-07-10	中山大学	治疗中枢神经系统退行性疾病的化合物及其应用
CN106279136B (zh) *	2016-08-15	2019-06-21	中山大学	治疗中枢神经系统退行性疾病或脑肿瘤的化合物及其应用
CN106957298B (zh) *	2017-04-18	2019-07-16	湖南中医药大学	一种硫辛酸苯酚酯衍生物及其制备方法和应用
CN107382987A (zh) *	2017-07-19	2017-11-24	佛山市第五人民医院	一种具有预防和治疗创伤性脑损伤活性的化合物及其制备方法和用途
EP3749697A4 (en)	2018-02-05	2021-11-03	Bio-Rad Laboratories, Inc.	CHROMATOGRAPHY RESIN WITH LIGAND MIXED MODE ANIONIC / HYDROPHOBIC EXCHANGE
CN112999220B (zh) *	2021-04-07	2022-12-13	中国人民解放军南部战区总医院	α-硫辛酸在作为和/或制备金属β-内酰胺酶抑制剂中的应用
CN115778930B (zh) *	2022-12-08	2024-02-27	陕西中医药大学	一种具有血管舒张活性的二硫缩醛类化合物在制备具有血管舒张活性药物方面的应用
WO2024216269A1 (en) *	2023-04-13	2024-10-17	The Regents Of The University Of California	Adjustably stable adhesive compositions for medical and non-medical uses, and recycling

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1205972B (de)	1963-08-20	1965-12-02	Merck Ag E	Verfahren zur Herstellung eines Liponsaeure-derivates
US4938636A (en)	1988-11-14	1990-07-03	Aidlin Automation Corp.	Method and apparatus for feeding container bodies
JPH06250330A (ja) *	1993-03-01	1994-09-09	Konica Corp	写真フィルムの加工方法
CZ96798A3 (cs) *	1997-04-02	1998-10-14	Sankyo Company Limited	Deriváty dithiolanu, jejich příprava a jejich terapeutické účinky
WO2000006550A1 (fr) *	1998-07-31	2000-02-10	Nippon Soda Co., Ltd.	Composes phenylazole, procede de production desdits composes et medicaments pour le traitement de l'hyperlipidemie
IL142824A0 (en) *	1998-10-26	2002-03-10	Univ New York State Res Found	Lipoic acid derivatives and their use in treatment of disease
US6369098B1 (en) *	1999-10-05	2002-04-09	Bethesda Pharmaceuticals, Inc.	Dithiolane derivatives
US6492405B2 (en) *	1999-12-30	2002-12-10	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Nitric oxide donors and pharmaceutical compositions containing them
US6387945B2 (en) *	2000-04-11	2002-05-14	The Regents Of The University Of California	Lipoic acid analogs

2000
- 2000-03-30 AR ARP000101441A patent/AR042572A1/es active IP Right Grant
- 2000-03-31 MY MYPI20001317A patent/MY119231A/en unknown
- 2000-03-31 US US09/937,823 patent/US6605637B1/en not_active Expired - Fee Related
- 2000-03-31 CA CA002369071A patent/CA2369071A1/fr not_active Abandoned
- 2000-03-31 ES ES00918930T patent/ES2193949T3/es not_active Expired - Lifetime
- 2000-03-31 CN CNB008069778A patent/CN1173969C/zh not_active Expired - Fee Related
- 2000-03-31 JP JP2000609410A patent/JP2003505341A/ja active Pending
- 2000-03-31 PT PT00918930T patent/PT1169316E/pt unknown
- 2000-03-31 AU AU39709/00A patent/AU763572B2/en not_active Ceased
- 2000-03-31 DE DE60001546T patent/DE60001546T9/de not_active Expired - Fee Related
- 2000-03-31 AT AT00918930T patent/ATE233752T1/de not_active IP Right Cessation
- 2000-03-31 PL PL00350994A patent/PL350994A1/xx unknown
- 2000-03-31 HU HU0200863A patent/HUP0200863A3/hu unknown
- 2000-03-31 WO PCT/FR2000/000814 patent/WO2000059899A1/fr active IP Right Grant
- 2000-03-31 NZ NZ514888A patent/NZ514888A/xx not_active IP Right Cessation
- 2000-03-31 EP EP00918930A patent/EP1169316B9/fr not_active Expired - Lifetime
- 2000-03-31 KR KR1020017012615A patent/KR100758763B1/ko not_active IP Right Cessation
- 2000-03-31 DK DK00918930T patent/DK1169316T3/da active
- 2000-04-01 TW TW089106172A patent/TWI269794B/zh active
2002
- 2002-10-10 HK HK02107396.3A patent/HK1046134B/zh not_active IP Right Cessation
2003
- 2003-04-21 US US10/419,671 patent/US6887891B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP0200863A2 (en)	2002-08-28
MY119231A (en)	2005-04-30
CA2369071A1 (fr)	2000-10-12
EP1169316B1 (fr)	2003-03-05
CN1349523A (zh)	2002-05-15
KR100758763B1 (ko)	2007-09-14
HK1046134B (zh)	2005-04-22
KR20010108444A (ko)	2001-12-07
ATE233752T1 (de)	2003-03-15
CN1173969C (zh)	2004-11-03
DE60001546T2 (de)	2004-02-19
EP1169316B9 (fr)	2003-10-29
DE60001546T9 (de)	2004-11-04
WO2000059899A8 (fr)	2001-03-22
HUP0200863A3 (en)	2005-02-28
PL350994A1 (en)	2003-02-24
JP2003505341A (ja)	2003-02-12
NZ514888A (en)	2002-12-20
ES2193949T3 (es)	2003-11-16
AU763572B2 (en)	2003-07-24
DE60001546D1 (de)	2003-04-10
AR042572A1 (es)	2005-06-29
AU3970900A (en)	2000-10-23
EP1169316A1 (fr)	2002-01-09
US6605637B1 (en)	2003-08-12
US20040019084A1 (en)	2004-01-29
TWI269794B (en)	2007-01-01
DK1169316T3 (da)	2003-06-30
US6887891B2 (en)	2005-05-03
HK1046134A1 (en)	2002-12-27
WO2000059899A1 (fr)	2000-10-12

Publication	Publication Date	Title
PT1169316E (pt)	2003-07-31	Novos derivados do acido lipoico sua preparacao e composicoes farmaceuticas que os contem
PT1202965E (pt)	2005-01-31	Derivados de indol processos para a sua preparacao composicoes farmaceuticas que os contem e a sua aplicacao
PT1095932E (pt)	2004-09-30	Derivados de acido fenoxiacetico e composicoes medicinais que os contem
PT1150961E (pt)	2004-02-27	Derivados do acido pirazolecarboxilico processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT1077692E (pt)	2004-12-31	Preparacoes farmaceuticas estabilizadas de derivados do acido aminobutirico e processos para a sua preparacao
PT1042323E (pt)	2002-09-30	Novos analogos tetraciclicos de camptotecinas processos para a sua preparacao sua utilizacao como medicamentos e composicoes farmaceuticas que os contem
PT1042324E (pt)	2003-06-30	Compostos heterociclicos para inibicao da secrecaode acido gastrico processis para a sua prepara cao e suas composicoes farmaceuticas
PT92699A (pt)	1990-06-29	Processo para a preparacao de novos derivados heterociclicos inibidores da enzima 5-lipoxigenase e de composicoes farmaceuticas que os contem
PT1572708E (pt)	2006-07-31	Novos derivados de fluoroglicosidos heterociclicos, produtos farmaceuticos que contem estes compostos e sua utilizacao
EE200000725A (et)	2002-06-17	Uued 3-arüülpropaanhappe derivaadid ja nende analoogid
PT876362E (pt)	2004-02-27	Novos taxoides sua preparacao e composicoes farmaceuticas que os contem
PT1192122E (pt)	2004-03-31	Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem
PT918759E (pt)	2003-01-31	Novos derivados de tiazolidino-2,4-diona substituidos processos para a sua obtencao e as composicoes farmaceuticas que os contem
PT91287A (pt)	1990-02-08	Processo de preparacao de derivados do acido indazol-3-carboxilico e de composicoes farmaceuticas que os contem
PT84319B (pt)	1989-09-14	Processo para a preparacao de derivados substituidos de tienoimidazol e de composicoes farmaceuticas que os contem
PT97114A (pt)	1991-11-29	Processo para a preparacao de derivados de hidantoina e de composicoes farmaceuticas que os contem
PT1049721E (pt)	2002-05-31	Polissacaridos de sintese processo para a sua preparacao e composicoes farmaceuticas que os contem
PT99795A (pt)	1993-04-30	Processo para a preparacao e novos derivados de piperidinil-benzimidazol e de composicoes farmaceuticas que os contem
PT89486A (pt)	1989-10-04	Processo para a preparacao de derivados 16-de-hidro de vitamina d3 e de composicoes farmaceuticas que os contem
PT83558B (pt)	1989-05-31	Processo para a preparacao de derivados da carboxamida e de composicoes farmaceuticas que os contem
PT1187847E (pt)	2004-04-30	Derivados de estreptograminas sua preparacao e as composicoes que os contem
PT90864A (pt)	1989-12-29	Processo para a preparacao de derivados de cromano e de composicoes farmaceuticas que os contem
PT1242389E (pt)	2004-08-31	Novos derivados ramificados de 3-amino-1-fenil-h¬1,2,4\|pirazole substituidos em amino processos para a sua preparacao e composicoes farmaceuticas que os contem
PT1118610E (pt)	2002-11-29	Novos derivados de benzeno-sulfonamida processo para a sua preparacao e as composicoes farmaceuticas que os contem
PT90904A (pt)	1989-12-29	Processo para a preparacao de derivados de 3-oxo-propanonitrilo triciclicos e de composicoes farmaceuticas que os contem